EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

β-alanine alleviates gout by inhibiting NLRP3 inflammasome activation

Xia-Ying Chen, Peng-Peng Zhu, Ying Yuan iD, Min-Yi Feng, Yu-Qin Xu, Liu-Bing Yu, Wen Xue, Yu Yu, Tao Li, Tao Zhou

Journal of Molecular Cell Biology · 2026

DOI: 10.1093/jmcb/mjag004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, 2026. Verfasst von Xia-Ying Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, beta-Alanine, Inflammasomes, Gout. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NLRP3 inflammasome plays a pivotal role in mediating pro-inflammatory cytokine release and inducing pyroptosis. Its aberrant activation is implicated in various inflammatory diseases, including gout, a condition characterized by monosodium urate crystal deposition in the ankle joint. Here, we identify β-alanine, an endogenous amino acid, as a novel NLRP3 inflammasome inhibitor with promising therapeutic potential for gout. Mechanistic investigations reveal that β-alanine binds to NLRP3, sequestering it within the trans-Golgi network. This interaction disrupts NLRP3 inflammasome assembly, thereby inhibiting the secretion of interleukin-1β (IL-1β) and IL-18. Moreover, in vivo experiments demonstrate that β-alanine administration significantly alleviates monosodium urate crystal-induced inflammation and joint swelling in mice without evident toxicity. Collectively, our findings not only uncover a novel endogenous regulatory mechanism for NLRP3-driven inflammation but also position β-alanine as a potential therapeutic candidate for gout.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 Proteinbeta-AlanineInflammasomesGoutAnimalsMiceUric AcidHumansInterleukin-1betaInflammationMice, Inbred C57BLMaleInterleukin-18

Stichwörter der Autor:innen

NLRP3goutinflammasomemonosodium urateβ-alanine

Substanzen

NLR Family, Pyrin Domain-Containing 3 Proteinbeta-AlanineInflammasomesUric AcidNlrp3 protein, mouseInterleukin-1betaInterleukin-18

Autor:innen und Institutionen

  • Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China.
  • Nanhu Laboratory, National Center of Biomedical Analysis, Beijing 100039, China.

ORCID-Profile: Ying Yuan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, X. Y., Zhu, P. P., Yuan, Y., Feng, M. Y., Xu, Y. Q., Yu, L. B., Xue, W., Yu, Y., Li, T., & Zhou, T. (2026). β-alanine alleviates gout by inhibiting NLRP3 inflammasome activation. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjag004

Vancouver

Chen XY, Zhu PP, Yuan Y, Feng MY, Xu YQ, Yu LB, et al. β-alanine alleviates gout by inhibiting NLRP3 inflammasome activation. Journal of Molecular Cell Biology. 2026. doi:10.1093/jmcb/mjag004

BibTeX
@article{Chen2026,
  author = {Chen, Xia-Ying and Zhu, Peng-Peng and Yuan, Ying and Feng, Min-Yi and Xu, Yu-Qin and Yu, Liu-Bing and Xue, Wen and Yu, Yu and Li, Tao and Zhou, Tao},
  title = {β-alanine alleviates gout by inhibiting NLRP3 inflammasome activation},
  journal = {Journal of Molecular Cell Biology},
  year = {2026},
  doi = {10.1093/jmcb/mjag004}
}
Kostenlos starten →